Inhibitors or modulators of these inflammatory or metabolic pathways, such as those of SNAP-25, may be developed to mitigate PCOS-associated inflammation, improving ovarian function and metabolic outcomes. Here, SNAP25 is linked to polycystic ovary syndrome.